DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Contribución de congreso (ConferenceOutput)
Oxidative stress, altered dopamine neurotransmission and increased susceptibility to nigrostriatal neurodegeneration in diabetic mice
Póster presentado al 6th Symposium on Biomedical Research: Advances and Perspectives in Molecular Endocrinology "In Homage to Gabriella Morreale", celebrado en el Instituto de Investigaciones Biomédicas Alberto Sols (IIBM-CSIC) el 31 de mayo de 2019., Diabetes has been associated with increased risk of neurodegenerative diseases in a number of epidemiological studies, but the underlying mechanisms are unknown. In the case of Parkinson’s disease, this association has been confirmed in an increasing number of reports, although other fail to find a link. Here, using a mouse model of diabetes, we describe oxidative stress and neurotransmission alterations in the nigrostriatal system, and investigate whether diabetes increases the vulnerability
of substantia nigra neurons to neurodegeneration. We used C57BL/6 mice rendered diabetic by streptozocin injections. Dopaminergic neuron and oxidative stress markers were determined by RT-qPCR or western blot. Striatal neurotransmitter and related metabolite levels were monitored by HPLC. Oxidative stress in the striatum was determined using commercial tests. [3H]-Dopamine uptake was assessed using striatal synaptosomes. After unilateral striatal injections of a sub-threshold dose of
6OHDA, motor performance was assessed using standard tests and neurodegenerative damage was histologically studied. The expression of genes involved in the regulation of the defense response against oxidative stress, including Nrf2, Keap1, Foxo1, catalase and SOD2 was altered in the substantia nigra of diabetic mice. SOD2 protein levels were unaffected, but catalase levels and activity were reduced. Oxidative stress was confirmed by elevated 4-HNE in the striatum. Diabetes resulted in decreased levels of dopamine and their metabolites in the striatum, without affecting those of noradrenaline or serotonine. Functional changes in neurotransmission were documented by reduced levels of the dopamine transporter DAT, the potassium channel Girk2, and the presynaptic vesicle markers VMAT2 and Syb2. However, dopamine reuptake was not significantly affected in diabetic animals. Finally, histological and motor performance tests revealed increased damage and motor impairment after 6OHDA injections in diabetic mice. Our data indicate that diabetic mice develop striatal oxidative stress and present altered striatal dopaminergic neurotransmission as well as increased vulnerability of nigrostriatal neurons to neurodegenerative damage, providing new insights into the pathophysiology of a possible relationship between diabetes and Parkinson’s disease., BFU2014-52149-R and BFU2017-89336-R to M.V.; SAF2016-78207-R and PCIN-2015-098 to R.M; FPU 14/04457 to I.P.T., Peer reviewed
Proyecto:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 BFU2014-52149-R
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 BFU2017-89336-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2016-78207-R
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 PCIN-2015-098